DK1170591T3 - Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midler - Google Patents
Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midlerInfo
- Publication number
- DK1170591T3 DK1170591T3 DK01115703T DK01115703T DK1170591T3 DK 1170591 T3 DK1170591 T3 DK 1170591T3 DK 01115703 T DK01115703 T DK 01115703T DK 01115703 T DK01115703 T DK 01115703T DK 1170591 T3 DK1170591 T3 DK 1170591T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- therapeutic agents
- identifying combinations
- identifying
- combinations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61183500A | 2000-07-07 | 2000-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1170591T3 true DK1170591T3 (da) | 2005-10-10 |
Family
ID=24450586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01115703T DK1170591T3 (da) | 2000-07-07 | 2001-07-05 | Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midler |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20020019010A1 (de) |
| EP (2) | EP1586900A3 (de) |
| JP (1) | JP3790447B2 (de) |
| KR (1) | KR100470825B1 (de) |
| CN (1) | CN1452719A (de) |
| AR (1) | AR029581A1 (de) |
| AT (1) | ATE298424T1 (de) |
| AU (1) | AU2001271841A1 (de) |
| BR (1) | BR0102781A (de) |
| CA (1) | CA2352515C (de) |
| DE (1) | DE60111595T2 (de) |
| DK (1) | DK1170591T3 (de) |
| ES (1) | ES2243367T3 (de) |
| IL (1) | IL144049A (de) |
| MX (1) | MXPA01006914A (de) |
| NZ (2) | NZ524186A (de) |
| PT (1) | PT1170591E (de) |
| SG (1) | SG148027A1 (de) |
| TW (1) | TWI240074B (de) |
| WO (1) | WO2002004946A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1243327A1 (de) * | 2001-03-19 | 2002-09-25 | BioChip Technologies GmbH | Oberfläche mit einem Muster aus Zellen und Verfahren zu deren Herstellung |
| TW573125B (en) * | 2001-08-29 | 2004-01-21 | Combinatorx Inc | A screening system for identifying drug-drug interactions and methods of use thereof |
| EP1656124A1 (de) * | 2003-03-12 | 2006-05-17 | Cerenis | Methoden und verbindungen zur krebsbehandlung |
| US7264933B2 (en) | 2003-03-26 | 2007-09-04 | Synergy Biosystems Ltd | Methods to identify biologically active agents and synergistic combinations |
| US20040253642A1 (en) * | 2003-06-06 | 2004-12-16 | Grant Zimmermann | System and method for multidimensional evaluation of combinations of compositions |
| US7419820B2 (en) * | 2003-12-16 | 2008-09-02 | Canon Kabushiki Kaisha | Transfer sheet for transferring biologically active substance to culture plate |
| JP4632400B2 (ja) | 2003-12-16 | 2011-02-16 | キヤノン株式会社 | 細胞培養用基板、その製造方法、それを用いた細胞スクリーニング法 |
| US20060040338A1 (en) * | 2004-08-18 | 2006-02-23 | Odyssey Thera, Inc. | Pharmacological profiling of drugs with cell-based assays |
| EP2089723A2 (de) * | 2006-11-13 | 2009-08-19 | University of Wyoming | Vorrichtung und verfahren zum messen der fluoreszenz grosser mehrzelliger organismen |
| WO2009151511A1 (en) * | 2008-04-29 | 2009-12-17 | Therasis, Inc. | Systems and methods for identifying combinations of compounds of therapeutic interest |
| CN104090094A (zh) * | 2013-05-28 | 2014-10-08 | 长兴化学工业股份有限公司 | 生物医学装置 |
| EP3374751B1 (de) * | 2015-11-13 | 2024-01-24 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Fixierungsmittel und verfahren zu deren verwendung |
| DE102020202529A1 (de) * | 2020-02-27 | 2021-09-02 | Robert Bosch Gesellschaft mit beschränkter Haftung | Verfahren zur Identifikation einer Wirkstoffkombination |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| CA2058252A1 (en) * | 1991-03-18 | 1992-09-19 | Linda R. Robertson | Synergistic product selection test for biocides |
| US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
| US5985356A (en) * | 1994-10-18 | 1999-11-16 | The Regents Of The University Of California | Combinatorial synthesis of novel materials |
| US5756304A (en) * | 1995-07-14 | 1998-05-26 | Molecular Solutions | Screening of microorganisms for bioremediation |
| US5989835A (en) * | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
| US6030942A (en) * | 1996-08-30 | 2000-02-29 | The Trustees Of The University Of Pennsylvania | Peptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductase |
| EP0981514B1 (de) * | 1997-05-16 | 2006-04-05 | Woman & Infants Hospital | 3-epi-vitamin d2 verbindungen und ihre anwendungen |
| US5985214A (en) * | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
| US5992226A (en) * | 1998-05-08 | 1999-11-30 | The United States Of America As Represented By The Secretary Of The Navy | Apparatus and method for measuring intermolecular interactions by atomic force microscopy |
| US6219674B1 (en) * | 1999-11-24 | 2001-04-17 | Classen Immunotherapies, Inc. | System for creating and managing proprietary product data |
| US7266458B2 (en) * | 2000-03-06 | 2007-09-04 | Bioseek, Inc. | BioMAP analysis |
-
2001
- 2001-03-22 US US09/815,417 patent/US20020019010A1/en not_active Abandoned
- 2001-03-22 US US09/815,429 patent/US20020019011A1/en not_active Abandoned
- 2001-06-28 IL IL144049A patent/IL144049A/en not_active IP Right Cessation
- 2001-07-01 NZ NZ524186A patent/NZ524186A/en unknown
- 2001-07-05 DE DE60111595T patent/DE60111595T2/de not_active Expired - Fee Related
- 2001-07-05 KR KR10-2001-7011539A patent/KR100470825B1/ko not_active IP Right Cessation
- 2001-07-05 CN CN01815353A patent/CN1452719A/zh active Pending
- 2001-07-05 DK DK01115703T patent/DK1170591T3/da active
- 2001-07-05 AU AU2001271841A patent/AU2001271841A1/en not_active Abandoned
- 2001-07-05 WO PCT/US2001/021292 patent/WO2002004946A2/en active Application Filing
- 2001-07-05 EP EP05013343A patent/EP1586900A3/de not_active Withdrawn
- 2001-07-05 PT PT01115703T patent/PT1170591E/pt unknown
- 2001-07-05 SG SG200502530-9A patent/SG148027A1/en unknown
- 2001-07-05 AT AT01115703T patent/ATE298424T1/de not_active IP Right Cessation
- 2001-07-05 ES ES01115703T patent/ES2243367T3/es not_active Expired - Lifetime
- 2001-07-05 EP EP01115703A patent/EP1170591B1/de not_active Expired - Lifetime
- 2001-07-06 AR ARP010103237A patent/AR029581A1/es not_active Application Discontinuation
- 2001-07-06 CA CA002352515A patent/CA2352515C/en not_active Expired - Lifetime
- 2001-07-06 MX MXPA01006914A patent/MXPA01006914A/es active IP Right Grant
- 2001-07-06 NZ NZ512821A patent/NZ512821A/en unknown
- 2001-07-09 BR BR0102781-6A patent/BR0102781A/pt not_active IP Right Cessation
- 2001-07-09 JP JP2001208607A patent/JP3790447B2/ja not_active Expired - Fee Related
- 2001-09-21 TW TW090116629A patent/TWI240074B/zh active
-
2006
- 2006-04-18 US US11/379,179 patent/US20060177877A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1586900A2 (de) | 2005-10-19 |
| MXPA01006914A (es) | 2004-10-15 |
| EP1586900A3 (de) | 2005-12-14 |
| DE60111595D1 (de) | 2005-07-28 |
| BR0102781A (pt) | 2002-03-12 |
| CN1452719A (zh) | 2003-10-29 |
| JP3790447B2 (ja) | 2006-06-28 |
| PT1170591E (pt) | 2005-11-30 |
| ATE298424T1 (de) | 2005-07-15 |
| TWI240074B (en) | 2005-09-21 |
| WO2002004946A2 (en) | 2002-01-17 |
| NZ512821A (en) | 2003-05-30 |
| NZ524186A (en) | 2004-10-29 |
| EP1170591B1 (de) | 2005-06-22 |
| KR100470825B1 (ko) | 2005-03-08 |
| US20020019010A1 (en) | 2002-02-14 |
| US20020019011A1 (en) | 2002-02-14 |
| ES2243367T3 (es) | 2005-12-01 |
| KR20020065340A (ko) | 2002-08-13 |
| DE60111595T2 (de) | 2006-05-18 |
| WO2002004946A3 (en) | 2003-01-23 |
| US20060177877A1 (en) | 2006-08-10 |
| SG148027A1 (en) | 2008-12-31 |
| IL144049A (en) | 2006-12-10 |
| EP1170591A3 (de) | 2002-09-18 |
| AU2001271841A1 (en) | 2002-01-21 |
| CA2352515C (en) | 2007-06-19 |
| IL144049A0 (en) | 2002-04-21 |
| JP2002328124A (ja) | 2002-11-15 |
| EP1170591A2 (de) | 2002-01-09 |
| AR029581A1 (es) | 2003-07-02 |
| CA2352515A1 (en) | 2002-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| NO20042955L (no) | Substituerte fenylaftalener som estrogene midler | |
| DK1312239T3 (da) | Teknikker til undertrykkelse af interferens | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| DK1451143T3 (da) | Fremgangsmåder til fremstilling af O-desmethylvenlafaxin | |
| DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
| NO20021329D0 (no) | Kinaseinhibitorer som terapeutiske midler | |
| DK1423391T3 (da) | Pyrrolopyrimidiner som midler til inhibering af cysteinproteaser | |
| NO20030135L (no) | Piperidinforbindelser for anvendelse som CCR-3-inhibitorer | |
| NO20033618L (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
| DK1401828T3 (da) | N-Formylhydroxylaminforbindelser som inhibitorer af PDF | |
| AR027983A1 (es) | Novedosos compuestos | |
| DK1324970T3 (da) | Retinoider til behandling af emfysem | |
| DK1392318T3 (da) | 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse | |
| DK1170591T3 (da) | Fremgangsmåde til identifikation af kombinationer af forbindelser som terapeutiske midler | |
| DK1600441T3 (da) | Krystallinsk form af elrcanidipinhydrochlorid til anvendelse som et antihypertensivt middel | |
| DK1263717T3 (da) | Fremgangsmåde til fremstilling af methionin | |
| DE60220914D1 (de) | Aminoacetonitril-verbindungen zur bekämpfung von endoparasiten | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DK1326836T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin | |
| DK1294659T3 (da) | Fremgangsmåde til isolering af katamin | |
| IS7288A (is) | Aðferðir til að hreinsa levófloxasín | |
| AR028220A1 (es) | Novedosos compuestos | |
| DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
| DK1692137T3 (da) | Fremgangsmåde til fremstilling af tubulinininhibitorer |